MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Refining a Claims-Based Severity Rating Scale for Parkinson’s Disease Using Machine Learning

E. Krause, L. Kovalchick, A. Medhus, J. Theo, C. Truong, S. Park, X. Zhang, X. Jiang, T. Krause (Austin, USA)

Meeting: 2025 International Congress

Keywords: Parkinson’s, Scales

Category: Parkinson's Disease: Epidemiology, Phenomenology, Clinical Assessment, Rating Scales

Objective: This project aimed to develop an advanced claims-based algorithm to assign severity level to people with Parkinson’s (PwP) to enhance research on disease progression. Specifically, the research team plans to evaluate the impact of environmental factors on the progression of Parkinson’s Disease (PD) in Texas but devised an algorithm to identify severity levels first.

Background: Effective management of PD requires an accurate and dynamic assessment of disease severity to guide both pharmacological and non-pharmacological treatments. As the

severity of the disease symptoms increases, individualized therapeutic interventions become important to maintain optimal patient outcomes. Disease staging is useful for disease management but can also strengthen epidemiologic research measuring disease burden, patterns in progression, and treatment outcomes at a population level. In clinical practice and research, the severity of Parkinson’s disease is commonly measured with the Hoehn and Yahr scale and the Unified Parkinson’s Disease Rating Scale. Dahodwala et al also presented a pharmacy claims-based algorithm to identify advanced PD.

Method: The Texas All-Payor-Claims-Database (TX-APCD) contains claims for 76,768 PwP (~9% of the nation’s estimated prevalence). Applying prior strategies, we created an algorithm that abstracts diagnoses, symptoms, procedures, and levodopa equivalent dosage (LED) to assign severity level (Early, Mid, Late) to PwP in claims data. Testing of the algorithm left 11% of the PwP too ambiguous to assign a level. We then turned to artificial intelligence to improve the model. Random pairs of PwP were selected from the claims database and their demographics, medical and drug history were summarized. Neurologists who specialize in PD then applied their clinical judgment to assign severity levels. AI used reinforcement learning with text prompt to build an improved algorithm. The algorithm relies on a calculation table that assigns weighted points to factors derived from claims, resulting in a summed classification of early to late stage.

Results: A complex algorithm that incorporates key data from claims has been shown to perform well in severity assignment with minimal mismatches to clinical assessment.

Conclusion: The refined claims-based severity assignment algorithm will be utilized by our research team to assess the impact of environmental factors on the progression of Parkinson’s

Disease in Texas.

To cite this abstract in AMA style:

E. Krause, L. Kovalchick, A. Medhus, J. Theo, C. Truong, S. Park, X. Zhang, X. Jiang, T. Krause. Refining a Claims-Based Severity Rating Scale for Parkinson’s Disease Using Machine Learning [abstract]. Mov Disord. 2025; 40 (suppl 1). https://www.mdsabstracts.org/abstract/refining-a-claims-based-severity-rating-scale-for-parkinsons-disease-using-machine-learning/. Accessed October 5, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2025 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/refining-a-claims-based-severity-rating-scale-for-parkinsons-disease-using-machine-learning/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Insulin dependent diabetes and hand tremor
  • Improvement in hand tremor following carpal tunnel release surgery
  • Impact of expiratory muscle strength training (EMST) on phonatory performance in Parkinson's patients
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley